Marisa Cobanaj

Marisa Cobanaj

Auto-generated profile, based on publicly available information

Marisa Cobanaj

Helmholtz-Zentrum Dresden-Rossendorf

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2023 in European Journal of Cancer
Verified
Journal Article
Open access
MCMarisa Cobanaj
Marisa Cobanaj
CCChiara Corti
Chiara Corti
EDEdward C. Dee
Edward C. Dee
LMLucas McCullum
Lucas McCullum
LBLaura Boldrini
Laura Boldrini
CCCarmen Criscitiello
Carmen Criscitiello
Patient care workflows are highly multimodal and intertwined: the intersection of data outputs provided from different disciplines and in different formats remains one of the main challenges of modern oncology. Artificial Intelligence (AI) has the potential to revolutionize the current clinical practice of oncology owing to advancements in digitalization, database expansion, computational technologies, and algorithmic innovations that facilitate discernment of complex relationships in multimodal data. Within oncology, radiation therapy (RT) represents an increasingly complex working procedure, involving many labor-intensive and operator-dependent tasks. In this context, AI has gained momentum as a powerful tool to standardize treatment performance and reduce inter-observer variability in a time-efficient manner. This review explores the hurdles associated with the development, implementation, and maintenance of AI platforms and highlights current measures in place to address them. In examining AI's role in oncology workflows, we underscore that a thorough and critical consideration of these challenges is the only way to ensure equitable and unbiased care delivery, ultimately serving patients' survival and quality of life.

23 July 2024 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
MCMarie-Laure Charpignon
Marie-Laure Charpignon
LCLeo Anthony Celi
Leo Anthony Celi
MCMarisa Cobanaj
Marisa Cobanaj
RERene Eber
Rene Eber
AFAmelia Fiske
Amelia Fiske
RPRobin Pierce
Robin Pierce
The recent imperative by the National Institutes of Health to share scientific data publicly underscores a significant shift in academic research. Effective as of January 2023, it emphasizes that transparency in data collection and dedicated efforts towards data sharing are prerequisites for translational research, from the lab to the bedside. Given the role of data access in mitigating potential bias in clinical models, we hypothesize that researchers who leverage open-access datasets rather than privately-owned ones are more diverse. In this brief report, we proposed to test this hypothesis in the transdisciplinary and expanding field of artificial intelligence (AI) for critical care. Specifically, we compared the diversity among authors of publications leveraging open datasets, such as the commonly used MIMIC and eICU databases, with that among authors of publications relying exclusively on private datasets, unavailable to other research investigators (e.g., electronic health records from ICU patients accessible only to Mayo Clinic analysts). To measure the extent of author diversity, we characterized gender balance as well as the presence of researchers from low- and middle-income countries (LMIC) and minority-serving institutions (MSI) located in the United States (US). Our comparative analysis revealed a greater contribution of authors from LMICs and MSIs among researchers leveraging open critical care datasets (treatment group) than among those relying exclusively on private data resources (control group). The participation of women was similar between the two groups, albeit slightly larger in the former. Notably, although over 70% of all articles included at least one author inferred to be a woman, less than 25% had a woman as a first or last author. Importantly, we found that the proportion of authors from LMICs was substantially higher in the treatment than in the control group (10.1% vs. 6.2%, p<0.001), including as first and last authors. Moreover, we found that the proportion of US-based authors affiliated with a MSI was 1.5 times higher among articles in the treatment than in the control group, suggesting that open data resources attract a larger pool of participants from minority groups (8.6% vs. 5.6%, p<0.001). Thus, our study highlights the valuable contribution of the Open Data strategy to underrepresented groups, while also quantifying persisting gender gaps in academic and clinical research at the intersection of computer science and healthcare. In doing so, we hope our work points to the importance of extending open data practices in deliberate and systematic ways.

31 July 2025 in Critical Care Science
Verified
Journal Article
Open access
PDF file
NWNaira Link Woite
Naira Link Woite
RGRodrigo R. Gameiro
Rodrigo R. Gameiro
MLMarianna Leite
Marianna Leite
AHAlessandro Hammond
Alessandro Hammond
MCMarisa Cobanaj
Marisa Cobanaj
LCLeo Anthony Celi
Leo Anthony Celi
Artificial intelligence technologies are rapidly advancing and significantly impacting healthcare, particularly in critical care environments where rapid, precise decision-making is crucial. They promise reductions in clinical errors, enhanced diagnostic accuracy, optimized treatment plans, and better resource allocation. Artificial intelligence applications are widespread across medical fields, with numerous artificial intelligence/machine learning-enabled medical devices approved by […] ABSTRACT Artificial intelligence technologies are rapidly advancing and significantly impacting healthcare, particularly in critical care environments where rapid, precise decision-making is crucial. They promise reductions in clinical errors, enhanced diagnostic accuracy, optimized treatment plans, and better resource allocation. Artificial intelligence applications are widespread across medical fields, with numerous artificial intelligence/machine learning-enabled medical devices approved by […]

15 March 2024
Verified
Book Chapter
Closed access
CCChiara Corti
Chiara Corti
MCMarisa Cobanaj
Marisa Cobanaj
CCCarmen Criscitiello
Carmen Criscitiello
GCGiuseppe Curigliano
Giuseppe Curigliano

7 October 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
MCMarisa Cobanaj
Marisa Cobanaj
FLFranciska Lebbink
Franciska Lebbink
SSSergej Schneider
Sergej Schneider
ESEmilia Louisa Ernestine Schäfer
Emilia Louisa Ernestine Schäfer
KPKrishna Godino Padre
Krishna Godino Padre
FHFelix Horst
Felix Horst
Objective. Integrating in-beam magnetic resonance imaging (MRI) with proton therapy (PT) introduces magnetic fields (MFs) that affect proton beam transport and therefore require accurate incorporation into the treatment planning system (TPS) for magnetic resonance (MR)-integrated PT (MRiPT). This study experimentally validates Monte Carlo-based proton dose calculation in the presence of the MF in a research version of the commercial TPS RayStation for MRiPT, using a measured three-dimensional (3D) magnetic vector field map of a 0.32 T in-beam MR scanner combined with a horizontal proton pencil beam scanning beam line. Approach. An MR-compatible mapping framework was used to acquire a high-resolution 3D magnetic vector field map, subsequently implemented into the TPS following coordinate transformations. Proton spot patterns and square radiation fields at 100, 150, and 220 MeV were delivered with and without the MF present. Dose distributions in air were measured using a 2D ionisation chamber array at multiple positions and compared with TPS dose calculations by analysing lateral beam shifts and field shape deformations with local γ -analysis. Clinically relevant patient treatment fields were evaluated at different water-equivalent depths (WEDs) in a phantom. Main results. Implementation of the measured magnetic vector field map preserved field vector magnitude, orientation and spatial alignment within the TPS. Dose measurements showed energy- and position-dependent MF-induced effects, which were accurately reproduced by the TPS. Agreement in lateral beam shifts was within 1–3 mm, and γ -pass rates exceeded 97% for a 3%/3 mm local criterion (10% dose threshold). Similar agreement was observed for patient treatment fields throughout all WEDs. Significance. This work validates the TPS capability to accurately model MF-induced proton beam transport in air as well as in a water-equivalent phantom. The present workflow establishes a foundation for proton treatment planning in the presence of MFs and thereby contributes to the clinical implementation of MRiPT.

18 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MCMarie-Laure Charpignon
Marie-Laure Charpignon
LCLeo Anthony Celi
Leo Anthony Celi
MCMarisa Cobanaj
Marisa Cobanaj
RERene Eber
Rene Eber
AFAmelia Fiske
Amelia Fiske
RPRobin Pierce
Robin Pierce
The recent imperative by the National Institutes of Health to share scientific data publicly underscores a significant shift in academic research. Effective as of January 2023, it emphasizes that transparency in data collection and dedicated efforts towards data sharing are prerequisites for translational research, from the lab to the bedside. Given the role of data access in mitigating potential bias in clinical models, we hypothesize that researchers who leverage open-access datasets rather than privately-owned ones are more diverse. In this brief report, we proposed to test this hypothesis in the transdisciplinary and expanding field of artificial intelligence (AI) for critical care. Specifically, we compared the diversity among authors of publications leveraging open datasets, such as the commonly used MIMIC and eICU databases, with that among authors of publications relying exclusively on private datasets, unavailable to other research investigators (e.g., electronic health records from ICU patients accessible only to Mayo Clinic analysts). To measure the extent of author diversity, we characterized gender balance as well as the presence of researchers from low- and middle-income countries (LMIC) and minority-serving institutions (MSI). Our comparative analysis revealed a greater contribution of authors from LMICs and MSIs among researchers leveraging open critical care datasets than among those relying exclusively on private data resources. The participation of women was similar between the two groups, albeit slightly larger in the former. Notably, although over 70% of all articles included at least one author inferred to be a woman, less than 25% had a woman as a first or last author. Importantly, we found that the proportion of authors from LMICs was substantially higher in the treatment than in the control group (10.1% vs. 6.2%, p<0.001), including as first and last authors. Moreover, we found that the proportion of US-based authors affiliated with a MSI was 1.5 times higher among articles in the treatment than in the control group, suggesting that open data resources attract a larger pool of participants from minority groups (8.6% vs. 5.6%, p<0.001). Thus, our study highlights the valuable contribution of the Open Data strategy to underrepresented groups, while also quantifying persisting gender gaps in academic and clinical research at the intersection of computer science and healthcare. In doing so, we hope our work points to the importance of extending open data practices in deliberate and systematic ways. Author Summary: In light of the significance of data access to the mitigation of bias in clinical models, we hypothesize that researchers who leverage existing open-access datasets rather than privately-owned ones are more diverse. In this brief report, we propose to test this hypothesis in the transdisciplinary and expanding field of artificial intelligence for critical care. Specifically, we compare the diversity among authors of publications leveraging open datasets, such as the commonly used MIMIC and eICU databases, with that among authors of publications relying exclusively on private datasets, unavailable to other research investigators. To measure the extent of author diversity, we characterize gender balance, geographic diversity (i.e., the number of countries with which authors are affiliated and the income categories these countries map to), and the presence of researchers from minority-serving institutions located in the United States. Furthermore, we comment on the challenges of increasing the participation of researchers from underrepresented groups and suggest changes that can be made to the current Open Data strategy to enhance representation in authorship in the next decade. By evaluating the association between data accessibility and author diversity, our study pinpoints actionable steps that the broader field of clinical AI can take to foster inclusion in the scientific community and mitigate blind spots in data preparation and/or model development.